#research

Photo

Risk assessment

Understanding the spread of COVID-19 on public transport

Researchers at Newcastle University are involved in a study to understand the risks of COVID-19 transmission on public transport and to identify the best measures to control it. Known as Project TRACK (Transport Risk Assessment for Covid Knowledge), the study will conduct fieldwork on buses and trains in London, Leeds and Newcastle, including the Metro system in Tyne and Wear.

Photo

At the heart of science

Scientific research has to be ‘passion-driven’, says Nobel Prize winner

Scientists cannot be expected to drop everything they’re working on to turn their attention to beating COVID-19, according to the winner of the 2019 Nobel Prize in Physiology or Medicine, Professor Sir Peter Ratcliffe. Speaking before he delivered the prestigious Michel Clavel lecture to the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, which was due to take place…

Photo

Flaws in study design

Will COVID-19 vaccines save lives? Right now, we cannot tell

Vaccines are being hailed as the solution to the COVID-19 pandemic, but the vaccine trials currently underway are not designed to tell us if they will save lives, reports Peter Doshi, Associate Editor at The BMJ. Several COVID-19 vaccine trials are now in their most advanced (phase 3) stage, but what will it mean exactly when a vaccine is declared “effective”? Many may assume that successful…

Photo

Improved patient response

Existing heart drugs may help with PD(L)1 immunotherapy

Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Angiotensin receptor II blockers (ARBs) are often prescribed for high blood pressure, heart failure,…

Photo

One mouse at a time

New approach to testing potential drugs for children’s cancers

A team of researchers in the US and Australia have developed a way of testing potential drugs for children’s cancers so as to take account of the wide genetic diversity of these diseases. In new research to be presented at the 32th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Professor Peter Houghton, director of the Greehey Children’s Cancer Research Institute (San…

Photo

Neuropilin-1 as a 'helper' for COVID-19

Coronavirus: Study finds further 'door opener' into the cell

The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2. An international research team under German-Finnish coordination has now identified neuropilin-1 as a factor that can facilitate SARS-CoV-2 entry into the cells’ interior. Neuropilin-1 is localized in the respiratory and olfactory epithelia, which could be a strategically important localization to contribute to…

Photo

'QCOVID' model

New COVID-19 tool predicts risks of hospital admission and death

A new risk tool, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from COVID-19 has been published by The BMJ. With cases increasing in the UK and elsewhere, and winter approaching, there is an urgent need for reliable models that predict the likely course of COVID-19, to support decisions about shielding, hospital admission, treatment, and…

Photo

Revealing innovation potential of new antibiotics

Using proteomic profiling to accelerate drug development

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents. The aim is to identify substances that attack the pathogens in a truly novel way. The team at the Center for Systems-Based Antibiotic Research (Cesar) at Ruhr-Universität Bochum (RUB) has described in two publications how assess if a new antibiotic…

Photo

Therapy development

New approach to 'BEAT' COVID-19

The present Coronavirus pandemic with all its effects on society – both health and economic – highlights the urgency of developing new therapies for COVID-19 treatment. At the same time, it demonstrates the necessity to become well prepared for new virus infections we may be facing in the future. To help control the current pandemic and brace for novel pathogens that may cause future…

Photo

COVID immunity research

Coronavirus re-infection: what we know so far – and the vital missing clues

As President Trump claims that he is immune to COVID-19 and isolated reports emerge of reinfection, what is the truth about immunity to COVID-19? To date, there have been six published cases of COVID-19 reinfection, with various other unverified accounts from around the world. Although this is a comparably small fraction of the millions of people known to have been infected, should we be…

Photo

Infection with Covid-19

The antiviral effect of innate immunity

Innate immunity is the fastest-acting component of the immune system, but so far little is known about its role during infection with SARS-CoV-2. A few hours after an infection, the body emits an alarm signal, interferon, enabling cells that have not yet been infected to produce antiviral proteins. This phenomenon occurs well before the production of neutralizing antibodies. Scientists from the…

Photo

Review highlight need

Lung cancer screening: experts appeal for wide implementation of LDCT

A new review, conducted by Professor John Field from the University of Liverpool and Professor Matthijs Oudkerk, University of Groningen, provides an authoritative insight into the current status of lung cancer screening. Lung cancer kills more people than any other cancer. The number of deaths in 2017 in the UK was 3,300, making lung cancer the commonest cause of cancer death in the UK for both…

Photo

Uncommon, but reversible

Sudden deaf: permanent hearing loss linked to COVID-19

Although uncommon, sudden permanent hearing loss seems to be linked to COVID-19 infection in some people, warn doctors, reporting the first UK case in the journal BMJ Case Reports. Awareness of this possible side effect is important, because a prompt course of steroid treatment can reverse this disabling condition, they emphasise. Sudden hearing loss is frequently seen by ear, nose and throat…

Photo

New insights on the virus' ‘survivability’

How long does SARS-CoV-2 last on surfaces?

Researchers at CSIRO, Australia's national science agency, have found that SARS-CoV-2, the virus responsible for COVID-19, can survive for up to 28 days on common surfaces including banknotes, glass – such as that found on mobile phone screens - and stainless steel.

Photo

Medicine, key nutrient, or both?

Risky misunderstandings about vitamin D

The professional perception of vitamin D as a medicine, rather than as a key nutrient, is constraining practice and jeopardising the health of elderly care home residents in England, conclude researchers in the journal BMJ Nutrition Prevention & Health. At a time when the vulnerability of elderly care home residents is under the spotlight because of the impact of COVID-19, an urgent review is…

Photo

Exploring new principles for therapeutic agents

New class of inhibitors to protect against neurodegeneration

Neurobiologists at Heidelberg University have discovered how a special receptor at neuronal junctions that normally activates a protective genetic programme can lead to nerve cell death when located outside synapses. Their fundamental findings on neurodegenerative processes simultaneously led the researchers at the Interdisciplinary Center for Neurosciences (IZN) to a completely new principle for…

Photo

"Enhance that"

New algorithm sharpens focus of cryo-electron microscopes

Scientists have developed a tool that improves the resolution and accuracy of powerful microscopes that are used to reveal insights into biology and medicine. In a study published in Nature Methods, a multi-institutional team led by Tom Terwilliger from the New Mexico Consortium and including researchers from Lawrence Berkeley National Laboratory (Berkeley Lab) demonstrates how a new computer…

2038 show more articles